Crossmark

SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis

Crossref DOI link: https://doi.org/10.1007/s12672-025-02093-2

Published Online: 2025-03-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gu, Jue

Wang, Yaxuan

Zhang, Hui

Gu, Haijuan

Zhu, Haixia
Funding

Funding for this research was provided by:

Scientific research project of Nantong Health Commission (MS2022041，MS2022053，MSZ2022147)

Nantong University Clinical Medicine Special Research fund (2023JY014, 2022LZ012)

Nantong Science and Technology Project (ntyx2208)
License Information

Text and Data Mining valid from 2025-03-15

Version of Record valid from 2025-03-15
More Information

Article History

Received: 19 November 2024

Accepted: 7 March 2025

First Online: 15 March 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below